Probiotics for Treatment of Acute Diarrhoea in Children: Randomised Clinical Trial of Five Different Preparations

Overview

Journal BMJ

Specialty General Medicine

Date 2007 Aug 11

PMID 17690340

Citations 80

Authors

Roberto Berni Canani

Pia Cirillo

Gianluca Terrin

Luisa Cesarano

Maria Immacolata Spagnuolo

Anna De Vincenzo

Fabio Albano

Annalisa Passariello

Giulio De Marco

Francesco Manguso

Alfredo Guarino

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the efficacy of five probiotic preparations recommended to parents in the treatment of acute diarrhoea in children. Design Randomised controlled clinical trial in collaboration with family paediatricians over 12 months.

Setting: Primary care.

Participants: Children aged 3-36 months visiting a family paediatrician for acute diarrhoea.

Intervention: Children's parents were randomly assigned to receive written instructions to purchase a specific probiotic product: oral rehydration solution (control group); Lactobacillus rhamnosus strain GG; Saccharomyces boulardii; Bacillus clausii; mix of L delbrueckii var bulgaricus, Streptococcus thermophilus, L acidophilus, and Bifidobacterium bifidum; or Enterococcus faecium SF68.

Main Outcome Measures: Primary outcomes were duration of diarrhoea and daily number and consistency of stools. Secondary outcomes were duration of vomiting and fever and rate of admission to hospital. Safety and tolerance were also recorded.

Results: 571 children were allocated to intervention. Median duration of diarrhoea was significantly shorter (P<0.001) in children who received L rhamnosus strain GG (78.5 hours) and the mix of four bacterial strains (70.0 hours) than in children who received oral rehydration solution alone (115.0 hours). One day after the first probiotic administration, the daily number of stools was significantly lower (P<0.001) in children who received L rhamnosus strain GG and in those who received the probiotic mix than in the other groups. The remaining preparations did not affect primary outcomes. Secondary outcomes were similar in all groups.

Conclusions: Not all commercially available probiotic preparations are effective in children with acute diarrhoea. Paediatricians should choose bacterial preparations based on effectiveness data.

Trial Registration Number: Current Controlled Trials ISRCTN56067537 [controlled-trials.com].

Citing Articles

Elevated rates and biased spectra of mutations in anaerobically cultured lactic acid bacteria.

Hale O, Yin M, Behringer M bioRxiv. 2025; .

PMID: 40060621 PMC: 11888475. DOI: 10.1101/2025.02.28.639667.

Soybean Flour Fortified with Powder to Increase Iron Bioavailability Improves Gut Health and Oxidative Balance In Vivo.

Barnabe M, Vicente L, Martins K, Lacerda G, Rodrigues E, Oliveira L Nutrients. 2025; 17(3).

PMID: 39940294 PMC: 11819770. DOI: 10.3390/nu17030437.

Post-transplant diarrhea in pediatric kidney transplant recipients.

McBee M, Butani L Pediatr Nephrol. 2025; .

PMID: 39907757 DOI: 10.1007/s00467-024-06572-6.

The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.

Guaman L, Carrera-Pacheco S, Zuniga-Miranda J, Teran E, Erazo C, Barba-Ostria C Nutrients. 2024; 16(21).

PMID: 39519539 PMC: 11547800. DOI: 10.3390/nu16213706.

Metagenomic analysis of rats with diarrhea treated with mixed probiotics: response to consecutive and alternate-hour supplementation.

Wang A, Cui X, Shi C Transl Pediatr. 2024; 13(8):1336-1358.

PMID: 39263297 PMC: 11384429. DOI: 10.21037/tp-24-129.

References

Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo M . Microbiological evaluation of commercial probiotic products available in Italy. J Chemother. 2004; 16(5):463-7. View

Young J . European market developments in prebiotic- and probiotic-containing foodstuffs. Br J Nutr. 1999; 80(4):S231-3. View

Szajewska H, Setty M, Mrukowicz J, Guandalini S . Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006; 42(5):454-75. DOI: 10.1097/01.mpg.0000221913.88511.72. View

Kurugol Z, Koturoglu G . Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005; 94(1):44-7. DOI: 10.1111/j.1651-2227.2005.tb01786.x. View

Oberhelman R, Gilman R, Sheen P, Taylor D, Black R, Cabrera L . A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr. 1999; 134(1):15-20. DOI: 10.1016/s0022-3476(99)70366-5. View

Guarino A, Canani R, Spagnuolo M, Albano F, Di Benedetto L . Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997; 25(5):516-9. DOI: 10.1097/00005176-199711000-00005. View

Guandalini S, Pensabene L, Zikri M, Dias J, Casali L, Hoekstra H . Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000; 30(1):54-60. DOI: 10.1097/00005176-200001000-00018. View

Guandalini S . Treatment of acute diarrhea in the new millennium. J Pediatr Gastroenterol Nutr. 2000; 30(5):486-9. DOI: 10.1097/00005176-200005000-00004. View

Szajewska H, Hoekstra J, Sandhu B . Management of acute gastroenteritis in Europe and the impact of the new recommendations: a multicenter study. The Working Group on acute Diarrhoea of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2000; 30(5):522-7. DOI: 10.1097/00005176-200005000-00011. View

10.

Davidson G, Butler R . Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr. 2000; 12(5):477-81. DOI: 10.1097/00008480-200010000-00010. View

11.

Farthing M . Novel targets for the pharmacotherapy of diarrhoea: a view for the millennium. J Gastroenterol Hepatol. 2000; 15 Suppl:G38-45. DOI: 10.1046/j.1440-1746.2000.02264.x. View

12.

Zimmerman C, Bresee J, Parashar U, Riggs T, Holman R, Glass R . Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatr Infect Dis J. 2001; 20(1):14-9. DOI: 10.1097/00006454-200101000-00004. View

13.

Guarino A, Albano F . Guidelines for the approach to outpatient children with acute diarrhoea. Acta Paediatr. 2001; 90(10):1087-95. DOI: 10.1080/080352501317061413. View

14.

Van Niel C, Feudtner C, Garrison M, Christakis D . Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002; 109(4):678-84. DOI: 10.1542/peds.109.4.678. View

15.

Huang J, Bousvaros A, Lee J, Diaz A, Davidson E . Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002; 47(11):2625-34. DOI: 10.1023/a:1020501202369. View

16.

Isolauri E . Probiotics for infectious diarrhoea. Gut. 2003; 52(3):436-7. PMC: 1773578. DOI: 10.1136/gut.52.3.436. View

17.

Alam N, Ashraf H . Treatment of infectious diarrhea in children. Paediatr Drugs. 2003; 5(3):151-65. DOI: 10.2165/00128072-200305030-00002. View

18.

Reid G, Jass J, Sebulsky M, McCormick J . Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003; 16(4):658-72. PMC: 207122. DOI: 10.1128/CMR.16.4.658-672.2003. View

19.

Allen S, Okoko B, Martinez E, Gregorio G, Dans L . Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2004; (2):CD003048. DOI: 10.1002/14651858.CD003048.pub2. View

20.

Fontana M, Zuin G, Pancheri P, Fusco F, Lambertini A, Canani R . Costs associated with outpatient diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP). Dig Liver Dis. 2004; 36(8):523-7. DOI: 10.1016/j.dld.2004.03.012. View